Product Description
Povidone-iodine (PVP-I), also known as iodopovidone, is an antiseptic used for skin disinfection before and after surgery. It may be used both to disinfect the skin of the patient and the hands of the healthcare providers. It may also be used for minor wounds. It may be applied to the skin as a liquid or a powder.
The Povidone Iodine (Pvp-I) market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Povidone Iodine (Pvp-I) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Povidone Iodine (Pvp-I) Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Povidone Iodine (Pvp-I) market are:
Adani Pharmachem
Glide Chem
Thatcher
Zen Chemicals
Quat Chem
Ashland
Zhongwei
Huaan Chemical
Boai NKY Pharmaceuticals
Sunflower
Nanhang Industrial
BASF
Most important types of Povidone Iodine (Pvp-I) products covered in this report are:
Medical Grade PVP-I
Industrial Grade PVP-I
Most widely used downstream fields of Povidone Iodine (Pvp-I) market covered in this report are:
Skin Sterilization
Infection Prevention
Instrument Sterilization
Food Industry
Breeding Industry
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.